Page 10 - Shauna Dillon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |ObsEva SA Announcements | ObsEva SA: ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses

Investegate announcements from ObsEva SA, ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses

United statesKarolinska institutetShauna dillonJacques donnezBrandi howardHugh taylorKristina gemzell danielssonProgram in uterine fibroidsInternational society of gynecological endocrinologyYale school of medicineSociety of endometriosisDrug administrationInternational societyEuropean commissionSwiss exchangeExchange commission

ObsEva Announces Appointment of Annette Clancy as Chair of the Board of Directors

ObsEva Announces Appointment of Annette Clancy as Chair of the Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomShauna dillonFrank verwielBrian ocallaghanAlliance managementAmerican management associationEuropean commissionDrug administrationBath university united kingdomSwiss exchangeExchange commissionEuropean medicines agencySwitzerland mayAnnette clancyAnnual general meeting

ObsEva Announces Appointment of Annette Clancy as Chair of the Board of Directors - Press Release

GENEVA, Switzerland May 19, 2022 – ObsEva SA OBSVOBSN)), a biopharmaceutical company developing and commercializing novel therapies for women's health

United statesUnited kingdomShauna dillonFrank verwielBrian ocallaghanAlliance managementAmerican management associationEuropean commissionDrug administrationBath university united kingdomSwiss exchangeExchange commissionEuropean medicines agencySwitzerland mayAnnette clancyAnnual general meeting

ObsEva SA: ObsEva Announces Appointment of Annette Clancy as Chair of the Board of Directors

GENEVA, Switzerland May 19, 2022 - ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women's health, today announced the appointment

United statesUnited kingdomShauna dillonFrank verwielBrian ocallaghanAlliance managementAmerican management associationEuropean commissionDrug administrationBath university united kingdomSwiss exchangeSwitzerland mayAnnette clancyAnnual general meetingAnnual generalBriano callaghan

ObsEva Announces Appointment of Annette Clancy as Chair of the Board of Directors

ObsEva Announces Appointment of Annette Clancy as Chair of the Board of Directors - read this article along with other careers information, tips and advice on BioSpace

United statesUnited kingdomShauna dillonFrank verwielBrian ocallaghanAlliance managementAmerican management associationEuropean commissionDrug administrationBath university united kingdomSwiss exchangeExchange commissionEuropean medicines agencySwitzerland mayAnnette clancyAnnual general meeting